ArticleThe Journal of allergy and clinical immunology2025

Integrative epidemiology and immunotranscriptomics uncover a risk and potential mechanism for cutaneous lymphoma unmasking or progression with dupilumab therapy.

Javier S Cabrera-Perez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.